Results 211 to 220 of about 16,593 (260)

A Dually Nanobody‐Engineered Milk‐Derived Extracellular Vesicle Nanomedicine Targeting Tumour‐Associated Macrophages and Cancer Cells for Cancer Therapy

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 2, February 2026.
ABSTRACT Tumour development and progression are driven by intricate interactions among various cell types within the tumour microenvironment (TME). Targeting a single cell type often fails to eradicate cancer, highlighting the need for strategies to co‐target multiple cell types.
Zhiang Liu   +14 more
wiley   +1 more source

Tuning Polyacrylate Composition to Recognize and Modulate Fluorescent Proteins

open access: yesAngewandte Chemie, Volume 138, Issue 2, 9 January 2026.
Random hetero oligomers (RHOs) of defined compositions are synthesized and fractionated to identify the chemical design criteria (charge, length, hydrophobicity) required to achieve nanomolar binding to green fluorescent protein, resulting in >100% fluorescence increases.
Darwin C. Gomez   +12 more
wiley   +2 more sources

Nanobodies and antibodies.

open access: green
Yeasmin Akter (7378415)   +5 more
openalex   +1 more source

Improving the production and stability of nanobodies

open access: green
Alba Pejenaute   +9 more
openalex   +2 more sources

Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling [PDF]

open access: bronze, 2014
Marek Pruszyński   +7 more
openalex   +1 more source

Her-2 nanobody modified cisplatin nanoparticles for precise chemotherapy of colon cancer

open access: green
Wenjun Liang   +4 more
openalex   +1 more source

Anti‐c‐MET Nanobody® – a new potential drug in multiple myeloma treatment [PDF]

open access: bronze, 2013
Tobias S. Slørdahl   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy